In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its..

The year began on a promising note as Bangladesh PM Sheikh Hasina thanked her Indian counterpart Narendra Modi for sending over two million doses of..

Even though Covishield has the WHO’s approval, the ‘Green Pass’ program only accommodates EMA-approved vaccines. The four COVID-19 vaccines approved by..

Previously there had been 30 cases of rare blood clot events reported out of the 18.1 million AstraZeneca/Oxford vaccine doses administered in Britain

The Centre on Monday said that the gap between the first and second doses of the AstraZeneca-Oxford University's Covishield vaccine should be increased to 6-8..

Ireland and The Netherlands became the latest countries to suspend the use of the AstraZeneca/Oxford University vaccine for their Covid-19 immunisation..

The 6,00,000 vaccines are part of an initial tranche of deliveries of the AstraZeneca/Oxford vaccine licensed to the Serum Institute of India.

The World Health Organization has listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these v

The WHO on Monday listed AstraZeneca and Oxford University's Covid-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the..

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

The UK government is "very confident" about the effectiveness of all the Covid-19 vaccines that the country has approved for use so far, despite South Africa's..

The Brazilian government announced Wednesday it was negotiating the purchase of 30 million coronavirus vaccine doses from Russia and India, after regulators made..

Pakistan's Drug Regulatory Authority has approved the emergency use of the Russian-made vaccine against the coronavirus disease, Gam-COVID-Vac, commonly known as..

The inoculation drive so far involves six million doses of the CoronaVac vaccine from China's Sinovac, and two million of the British AstraZeneca-Oxford jab,..

AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The..

DGCI on Sunday approved two vaccines - AstraZeneca-Oxford's Covishield and Bharat Biotech's Covaxin - for emergency use against COVID-19 in India.

The United Kingdom has ordered 100 million doses of the Oxford/AstraZeneca shot and is also rolling out a vaccine developed by Pfizer and BioNTech.

The Serum Institute of India (SII) clarified on Monday that the company is yet to receive the permission from the authority here to export its Covid-19 vaccine..

Serum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India's own..

A day ahead of the nationwide Covid-19 vaccination dry run, the Indian drug regulator's expert panel on Friday cleared the decks for emergency use authorisation..

The expert panel is likely to approve the vaccine developed by AstraZeneca and Oxford University for emergency use on Friday, Reuters reported quoting sources...

After AstraZeneca-Oxford vaccine Covishield got nod from regulators, there is a sense of optimism in the public, investors and market participants.

The British regulator approved AstraZeneca and Oxford’s vaccine on Wednesday, saying a gap of three months between shots could boost its efficacy.

CDSCO, India's drug regulator will meet on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use. SII, the world's..

UK on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major..

Britain on Wednesday (December 30) approved Oxford-Astrazeneca coronavirus vaccine for use against COVID-19. 

“The government has today accepted the recommendation from the MHRA to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use,” U.K. Health..

“The government has today accepted the recommendation from the MHRA to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use,” U.K. Health..

India is likely to have a COVID-19 vaccine approved for emergency use before December ends as Central Drugs Standard Control Organization's (CDSCO) expert panel..

This could be the first country to give the regulatory green light for the British drugmaker’s vaccine as the British medicine regulator continues to examine..

NEW DELHI: Pune-based vaccine-maker Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, on Saturday..

US regulators have approved the emergency use of the country's first COVID-19 vaccine from Pfizer and its German partner BioNTech for people aged 16 years and..

British pharmaceuticals group AstraZeneca, which is finalising a vaccine against Covid-19, said Saturday it was buying US biotech firm Alexion for $39 billion to..

After nine hours of non-stop debate, a high powered US vaccine advisory panel endorsed mass use of the Pfizer-BioNTech Covid-19 vaccine, putting the country just..

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a..

Serum Institute of India, the world's largest vaccine manufacturer, on Tuesday denied allegations that a Covid-19 trial volunteer suffered serious side effects..